afdx 384 has been researched along with Disease Models, Animal in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (33.33) | 18.2507 |
| 2000's | 1 (33.33) | 29.6817 |
| 2010's | 1 (33.33) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Dean, B; Gibbons, AS; Jeon, WJ; Scarr, E | 1 |
| Seidler, FJ; Slotkin, TA | 1 |
| Buccafusco, JJ; Zhang, LC | 1 |
3 other study(ies) available for afdx 384 and Disease Models, Animal
| Article | Year |
|---|---|
Changes in Muscarinic M2 Receptor Levels in the Cortex of Subjects with Bipolar Disorder and Major Depressive Disorder and in Rats after Treatment with Mood Stabilisers and Antidepressants.
Topics: Animals; Antidepressive Agents; Antimanic Agents; Bipolar Disorder; Cerebral Cortex; Depressive Disorder, Major; Disease Models, Animal; Female; Fluoxetine; Humans; Imipramine; Male; Middle Aged; Muscarinic Agonists; Oxotremorine; Pirenzepine; Radiopharmaceuticals; Rats, Sprague-Dawley; Receptor, Muscarinic M2; Tritium | 2016 |
Cholinergic receptor subtypes in the olfactory bulbectomy model of depression.
Topics: Alkaloids; Animals; Azocines; Brain; Depression; Disease Models, Animal; Gene Expression Regulation; Male; Muscarinic Antagonists; Olfactory Bulb; Parasympatholytics; Pirenzepine; Quinolizines; Radioligand Assay; Rats; Rats, Sprague-Dawley; Receptors, Cholinergic; Tritium | 2006 |
Prevention of morphine-induced muscarinic (M2) receptor adaptation suppresses the expression of withdrawal symptoms.
Topics: Animals; Behavior, Animal; Blood Pressure; Body Weight; Disease Models, Animal; Infusions, Intravenous; Injections, Subcutaneous; Isoflurophate; Male; Morphine; Morphine Dependence; Naloxone; Pirenzepine; Rats; Rats, Wistar; Receptor, Muscarinic M2; Receptors, Muscarinic; Substance Withdrawal Syndrome; Vasomotor System | 1998 |